Chronic red cell aplasia in adults is commonly due to autoimmune disease,' or to an intrinsic defect either in the pluripotent haemopoietic stem cell or in the maturation of its erythroid lineage. In the latter group evolution into marrow hypoplasia or leukaemia may occur. 2 We describe three cases in which the clinical manifestations of the disease were those of chronic anaemia due to red cell hypoplasia, but in whom the morphological picture was later suggestive of a chronic myeloproliferative or myelodysplastic disease.
Case reports CASE 1 A 49 year old man presented in 1981 with symptoms of a hiatus hernia. He had a history of occupational exposure to trichlorethylene. Physical examination yielded normal results apart from pallor. Routine testing showed a haemoglobin concentration of 7-6 g/dl, mean cell volume (MCV) 109 fl, with a dimorphic blood picture; a white cell count of Bone marrow blasts were between 5 and 10%. A course of Cis-retinoic acid improved his leucocyte and platelet counts, but had no effect on the haemoglobin concentration. Shortly before his death from cardiac failure in October 1987 his platelet count fell and the white cell count rose to 58 x 109/l (myeloblasts 6-38 x 109/1 and basophils 9-8 x I09/l). At necropsy, there was evidence of severe haemosiderosis. The spleen weighed 3-1 kg and showed infiltration by granulocytic cells. CASE 3 A 75 year old woman presented in 1985 with six months oflethargy; she was clinically anaemic but had no splenomegaly. Her medical and drug history were unremarkable. She had a macrocytic anaemia (haemoglobin concentration of 5 g/dl) which did not respond to empirical treatment with vitamin B,2 and folic acid.
On further investigation her haemoglobin concentration was 3-5 g/dl and her MCV 131 fl, with some teardrop cells. The white cell count was 7-4 x 109/1 (neutrophils 6-7 x 109/l), the platelet count normal, reticulocytes 1 2% ESR 55 mm/first hour, the DAT negative. Sucrose lysis test was also negative. Serum B,2 and folate concentrations ,were normal. Biochemical profile showed no specific abnormality. Immunoglobulin concentrations were normal apart from a minimal increase in IgA; serum electrophoresis was normal and there were no autoantibodies. Thyroid function was normal. There was no evidence of thymoma on chest x-ray picture or computed tomography scan. Bone marrow examination showed erythroid hypoplasia with myelodysplasia. Chromosome analysis was normal (46XX) and granulocyte-macrophage colony forming cells (GM-CFCs) were greatly reduced at 2 per 10 cells.
After blood transfusion she was treated with prednisolone and her haemoglobin concentration rose to 1169 10 g/dl. Six months later the platelet count rose to 1088 x 109/l and the haemoglobin concentration began to fall (haemoglobin concentration 8 g/dl, MCV 120 fl, white cell count 41 x 109/l, with neutrophils 38-5 x 109/l, monocytes 0-4 x 10/l, and retics > 1%). There was no evidence of haemorrhage, and vitamin B,2 and folate estimations remained normal. NAP score reached 49/100 neutrophils. She developed signs of proximal myopathy induced by steroids and these were discontinued. A repeat marrow aspirate showed relapsing red cell aplasia. GM-CFCs were "low normal" (32 per 0I cells) and BFU-E very low at 3 per 10' cells. Because of the patient's frail state it was felt that simple supportive treatment would be appropriate, and she was maintained on regular blood transfusions. She developed evidence of a monocytic leukaemia (white cell count 22 x 109/l, with monocytes 13-2 x 109/l, a platelet count of 500 x 109/1, and haemoglobin concentration 6 g/dl) and died 30 months after the first diagnosis.
Discussion
These three patients have several features in common; they all originally presented with a chronic normochromic normocytic or macrocytic anaemia, reflecting a profound or fluctuating red cell hypoplasia, with subsequent development of thrombocytosis or granulocytosis, or both, in marrow and peripheral blood, with morphology suggesting myelodysplasia.
Erythroid hypoplasia and thrombocytosis,3 but not granulocytosis,4 have been described together in the context of the Sq-syndrome, while sideroblastic anaemia and thrombocytosis have been associated with chromosomal abnormalities.5 Repeated cytogenetic analyses in our cases, however, showed normal karyotypes, reported to be associated with longer survival in myelodysplastic syndromes.6 Our first patient has survived six years since diagnosis, while case 2 died ofcardiac failure due to iron overload after five and a half years. Nevertheless, all our cases showed distinctive bone marrow abnormalities suggestive of myelodysplasia; indeed, when erythroblasts were detected in the marrow of case 2, they were "Smegaloblastoid" and the marrow of this patient might then be deemed to have exhibited trilineage myelodysplasia. The persistent presence of immature cells in the blood of two patients in the absence of infection is also suggestive ofan intrinsic bone marrow disorder. Case 3 differed somewhat from the others in that the red cell hypoplasia fluctuated, though transfusions were required for long periods.
Cases 2 and 3 showed some response to corticosteroids, though neither showed any other evidence of autoimmune disease. This is of interest in the light of the finding of Bagby et al7 that some cases of Craig, Geary, Love, Liu-Yin myelodysplasia show partial response to high doses ofcorticosteroids. Only in case 3 was the improvement in haemoglobin sustained for any length of time, although the thrombocytosis persisted and the patient relapsed while receiving steroids.
Red cell aplasia is recognised as a preleukaemic disorder: for example, Dumont found that 17 of 38 de novo cases of chronic red cell aplasia eventually developed acute leukaemia. (Dumont J. Proceedings of the XV Congress of the International Society for Haematology, Jerusalem 1974). In a recent review of the literature, however, Fitchen found that the overall incidence ofleukaemia in this syndrome was only 7%.8 Case 2 developed acute leukaemia shortly before his death from cardiac failure, and case 1 has had a peripheral blast count of the order of 3 x 19/1 for two years. There are anecdotal reports of red cell aplasia complicating both chronic granulocytic leukaemia9 and agnogenic myeloid metaplasia.'°Our patients had neither the Ph chromosome nor a clinically important amount of reticulin on bone marrow trephine biopsy.
These cases are of interest because they seem to exhibit features of both myeloproliferative and myelodysplastic disease and are difficult to place within existing classifications of haematological malignancies. In a recent review of the morphological features of stem cell disorders, Weatherall concludes that it is quite common to encounter cases which are not easily classified within the current nosology of these syndromes." The above cases of red cell hypoplasia accompanied by proliferative features in other cell lines probably fall within the spectrum of what has previously been called "unclassifiable myeloproliferative disease".
